<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd"> 
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="brief-report"><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.3 20070202//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing.dtd?><?SourceDTD.Version 2.3?><?ConverterInfo.XSLTName nlm2jats3.xsl?><?ConverterInfo.Version 1?><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Front Microbiol</journal-id><journal-id journal-id-type="iso-abbrev">Front Microbiol</journal-id><journal-id journal-id-type="publisher-id">Front. Microbiol.</journal-id><journal-title-group><journal-title>Frontiers in Microbiology</journal-title></journal-title-group><issn pub-type="epub">1664-302X</issn><publisher><publisher-name>Frontiers Media S.A.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">9116292</article-id><article-id pub-id-type="doi">10.3389/fmicb.2022.872583</article-id><article-categories><subj-group subj-group-type="heading"><subject>Microbiology</subject><subj-group><subject>Perspective</subject></subj-group></subj-group></article-categories><title-group><article-title>Incorporating the Gut Microbiome in the Risk Assessment of Xenobiotics and Identifying Beneficial Components for One Health</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Ampatzoglou</surname><given-names>Antonis</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref><xref rid="c001" ref-type="corresp">
<sup>*</sup>
</xref><xref rid="fn002" ref-type="author-notes">
<sup>&#x02020;</sup>
</xref><uri xlink:href="http://loop.frontiersin.org/people/1672388/overview"/></contrib><contrib contrib-type="author"><name><surname>Gruszecka-Kosowska</surname><given-names>Agnieszka</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref><xref rid="aff3" ref-type="aff">
<sup>3</sup>
</xref><xref rid="fn002" ref-type="author-notes">
<sup>&#x02020;</sup>
</xref><uri xlink:href="http://loop.frontiersin.org/people/1674163/overview"/></contrib><contrib contrib-type="author"><name><surname>Torres-S&#x000e1;nchez</surname><given-names>Alfonso</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref><uri xlink:href="http://loop.frontiersin.org/people/1760043/overview"/></contrib><contrib contrib-type="author"><name><surname>L&#x000f3;pez-Moreno</surname><given-names>Ana</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref><xref rid="aff4" ref-type="aff">
<sup>4</sup>
</xref><uri xlink:href="http://loop.frontiersin.org/people/883011/overview"/></contrib><contrib contrib-type="author"><name><surname>Cerk</surname><given-names>Klara</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref><xref rid="fn002" ref-type="author-notes">
<sup>&#x02020;</sup>
</xref><uri xlink:href="http://loop.frontiersin.org/people/1758809/overview"/></contrib><contrib contrib-type="author"><name><surname>Ortiz</surname><given-names>Pilar</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref><uri xlink:href="http://loop.frontiersin.org/people/1476525/overview"/></contrib><contrib contrib-type="author"><name><surname>Monteoliva-S&#x000e1;nchez</surname><given-names>Mercedes</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref><uri xlink:href="http://loop.frontiersin.org/people/927054/overview"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Aguilera</surname><given-names>Margarita</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref><xref rid="aff4" ref-type="aff">
<sup>4</sup>
</xref><xref rid="c002" ref-type="corresp">
<sup>*</sup>
</xref><xref rid="fn002" ref-type="author-notes">
<sup>&#x02020;</sup>
</xref><uri xlink:href="http://loop.frontiersin.org/people/787920/overview"/></contrib></contrib-group><aff id="aff1"><sup>1</sup><institution>Department of Microbiology, Faculty of Pharmacy, University of Granada (UGR)</institution>, <addr-line>Granada</addr-line>, <country>Spain</country></aff><aff id="aff2"><sup>2</sup><institution>Centre of Biomedical Research, Institute of Nutrition and Food Technology &#x0201c;Jos&#x000e9; Mataix&#x0201d; (INYTA), UGR</institution>, <addr-line>Granada</addr-line>, <country>Spain</country></aff><aff id="aff3"><sup>3</sup><institution>Department of Environmental Protection, Faculty of Geology, Geophysics, and Environmental Protection, AGH University of Science and Technology</institution>, <addr-line>Krak&#x000f3;w</addr-line>, <country>Poland</country></aff><aff id="aff4"><sup>4</sup><institution>IBS: Instituto de Investigaci&#x000f3;n Biosanitaria ibs.</institution>, <addr-line>Granada</addr-line>, <country>Spain</country></aff><author-notes><fn fn-type="edited-by"><p>Edited by: Eugenia Bezirtzoglou, Democritus University of Thrace, Greece</p></fn><fn fn-type="edited-by"><p>Reviewed by: Ayixon S&#x000e1;nchez-Reyes, National Autonomous University of Mexico, Mexico; Manoj Kumar, ICMR-National Institute for Research in Environmental Health, India</p></fn><corresp id="c001">*Correspondence: Antonis Ampatzoglou, <email>ampatzoglou@ugr.es</email></corresp><corresp id="c002">Margarita Aguilera, <email>maguiler@ugr.es</email></corresp><fn fn-type="other" id="fn002"><p><sup>&#x02020;</sup>EU-FORA Fellowship Program Hosted at UGR-INYTA</p></fn><fn fn-type="other" id="fn004"><p>This article was submitted to Food Microbiology, a section of the journal Frontiers in Microbiology</p></fn></author-notes><pub-date pub-type="epub"><day>04</day><month>5</month><year>2022</year></pub-date><pub-date pub-type="collection"><year>2022</year></pub-date><volume>13</volume><elocation-id>872583</elocation-id><history><date date-type="received"><day>09</day><month>2</month><year>2022</year></date><date date-type="accepted"><day>31</day><month>3</month><year>2022</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2022 Ampatzoglou, Gruszecka-Kosowska, Torres-S&#x000e1;nchez, L&#x000f3;pez-Moreno, Cerk, Ortiz, Monteoliva-S&#x000e1;nchez and Aguilera.</copyright-statement><copyright-year>2022</copyright-year><copyright-holder>Ampatzoglou, Gruszecka-Kosowska, Torres-S&#x000e1;nchez, L&#x000f3;pez-Moreno, Cerk, Ortiz, Monteoliva-S&#x000e1;nchez and Aguilera</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p></license></permissions><abstract><p>Three areas of relevance to the gut microbiome in the context of One Health were explored; the incorporation of the microbiome in food safety risk assessment of xenobiotics; the identification and application of beneficial microbial components to various areas under One Health, and; specifically, in the context of antimicrobial resistance. Although challenging, focusing on the microbiota resilience, function and active components is critical for advancing the incorporation of microbiome data in the risk assessment of xenobiotics. Moreover, the human microbiota may be a promising source of beneficial components, with the potential to metabolize xenobiotics. These may have possible applications in several areas, e.g., in animals or plants for detoxification or in the environment for biodegradation. This approach would be of particular interest for antimicrobials, with the potential to ameliorate antimicrobial resistance development. Finally, the concept of resistance to xenobiotics in the context of the gut microbiome may deserve further investigation.</p></abstract><kwd-group><kwd>one health</kwd><kwd>gut microbiome</kwd><kwd>xenobiotics</kwd><kwd>microbiota disrupting chemicals</kwd><kwd>next-generation risk assessment</kwd><kwd>antimicrobial resistance</kwd><kwd>next-generation probiotics</kwd></kwd-group><counts><fig-count count="1"/><table-count count="0"/><equation-count count="0"/><ref-count count="85"/><page-count count="7"/><word-count count="5864"/></counts></article-meta></front><body><sec sec-type="intro" id="S1"><title>Introduction</title><p>The microbiome, a characteristic microbial community occupying a reasonably well-defined habitat with distinct physio-chemical properties, encompasses the microorganisms involved (microbiota), as well as their structural elements, metabolites, and surrounding environmental conditions (<xref rid="B11" ref-type="bibr">Berg et al., 2020</xref>). One Health (OH) is the holistic methodology of transdisciplinary cooperation to improve human, animal, plant, and environmental health simultaneously, and its adoption is continuously expanding (<xref rid="B13" ref-type="bibr">Centers for Disease Control and Prevention, 2020</xref>; <xref rid="B12" ref-type="bibr">Bronzwaer et al., 2021</xref>). Due to their functional potential and considering their associations with a range of diseases, microbiomes are key elements in the OH framework (<xref rid="B17" ref-type="bibr">Comitato Nazionale per la Biosicurezza, le Biotecnologie e le Scienze della Vita [CNBBSV], 2019</xref>; <xref rid="B45" ref-type="bibr">Merten et al., 2020</xref>). Their significance is partly due to pathogenic and commensal microbial transfer between humans, animals, and the environment and the human microbiome stands out with regards to its interactions with environmental and dietary chemicals that affect human health outcomes (<xref rid="B77" ref-type="bibr">Trinh et al., 2018</xref>). Of particular interest are the contact and mutual influence between the human gut microbiome (GM) and exogenous toxic chemicals, xenobiotics, focusing on their fate, metabolism, and toxicity (<xref rid="B48" ref-type="bibr">National Academies of Sciences, Engineering, and Medicine [NASEM], 2018</xref>; <xref rid="B1" ref-type="bibr">Abdelsalam et al., 2020</xref>).</p><p>Among xenobiotics, endocrine disrupting chemicals (EDCs) are especially important, and they have been associated with metabolic disorders, such as obesity, as well as with changes in the GM (<xref rid="B25" ref-type="bibr">G&#x000e1;lvez-Ontiveros et al., 2020</xref>; <xref rid="B3" ref-type="bibr">Aguilera et al., 2021</xref>). Recently the concept of microbiota disrupting chemicals (MDCs) has been proposed, which comprise EDCs and other xenobiotics with potential to alter the gut microbiota&#x02019;s composition and metabolism (<xref rid="B2" ref-type="bibr">Aguilera et al., 2020</xref>) via food ingestion, e.g., bisphenols and parabens (<xref rid="B4" ref-type="bibr">And&#x000fa;jar et al., 2019</xref>; <xref rid="B47" ref-type="bibr">Monteagudo et al., 2021</xref>; <xref rid="B60" ref-type="bibr">Robles-Aguilera et al., 2021</xref>).</p><p>The interactions between MDCs and the GM are complex. This is partly because multiple general mechanisms are involved including; direct effects of the MDC on the microbiome; altered epithelial-barrier functions (affecting uptake or excretion of MDCs); direct chemical transformations of MDCs; secondary transformation of host-generated metabolites (e.g., deconjugation by &#x003b2;-glucuronidases), and; altered expression of host-tissue metabolic enzymes and pathways (e.g., in the liver <italic>via</italic> microbial signaling molecules) (<xref rid="B78" ref-type="bibr">Ulluwishewa et al., 2011</xref>; <xref rid="B54" ref-type="bibr">Patterson and Turnbaugh, 2014</xref>; <xref rid="B56" ref-type="bibr">Peterson and Artis, 2014</xref>; <xref rid="B30" ref-type="bibr">Kelly et al., 2015</xref>; <xref rid="B66" ref-type="bibr">Selwyn et al., 2015</xref>, <xref rid="B67" ref-type="bibr">2016</xref>; <xref rid="B15" ref-type="bibr">Claus et al., 2016</xref>; <xref rid="B73" ref-type="bibr">Spanogiannopoulos et al., 2016</xref>; <xref rid="B48" ref-type="bibr">National Academies of Sciences, Engineering, and Medicine [NASEM], 2018</xref>). Although these interactions can decrease MDC exposure and toxicity effects, they can also increase them. For example, several bacterial phyla in the human GM can produce azoreductases, which have been shown to reduce azo dyes that are common in foods into mutagenic and carcinogenic aromatic amines (<xref rid="B57" ref-type="bibr">Rafii et al., 1990</xref>; <xref rid="B84" ref-type="bibr">Xu et al., 2007</xref>). Overall, the role of these complex interactions in modifying human susceptibility to MDCs is beginning to be elucidated.</p><p>Risk assessment (RA) is the science-based component of the food safety risk analysis framework, alongside risk management and risk communication. RA comprises; hazard identification; hazard characterization; exposure assessment, and; risk characterization (<xref rid="B16" ref-type="bibr">Codex Alimentarius Commission, 1999</xref>; <xref rid="B58" ref-type="bibr">Regulation (EC) No 178/2002, 2002</xref>). Traditionally, xenobiotic RA relies on data from animal experiments, human trials and/or human observational/epidemiological studies. Importantly, the extrapolation of this data across species or studied populations is not without challenge, partially due to GM variability and the complexity of MDC/GM interactions (<xref rid="B48" ref-type="bibr">National Academies of Sciences, Engineering, and Medicine [NASEM], 2018</xref>). Thus, the need for the incorporation of the GM in food safety RA of xenobiotics is well-justified (<xref rid="B45" ref-type="bibr">Merten et al., 2020</xref>) and by extension to MDCs.</p><p>Another area of relevance to the GM in the context of OH is the identification of beneficial taxa and derived components (e.g., enzymes and biocompounds) in the GM and their potential application. In this context, toxicomicrobiomics, which study the aforementioned microbiome-xenobiotic/MDC interactions, along with culturomics, which aim to cultivate components of the human GM through the use of optimized selective and/or enrichment culture conditions coupled with metagenomic taxa identification, can shed light on the microbiome&#x02019;s capacity to metabolize xenobiotics (<xref rid="B8" ref-type="bibr">Aziz, 2018</xref>; <xref rid="B32" ref-type="bibr">Lagier et al., 2018</xref>; <xref rid="B17" ref-type="bibr">Comitato Nazionale per la Biosicurezza, le Biotecnologie e le Scienze della Vita [CNBBSV], 2019</xref>; <xref rid="B1" ref-type="bibr">Abdelsalam et al., 2020</xref>; <xref rid="B39" ref-type="bibr">L&#x000f3;pez-Moreno et al., 2022</xref>) and by extension MDCs. Thus, these approaches can help identify GM components with beneficial effects under OH, for example detoxification activity (<xref rid="B38" ref-type="bibr">L&#x000f3;pez-Moreno et al., 2021b</xref>) or next-generation probiotics (NGPs) (<xref rid="B37" ref-type="bibr">L&#x000f3;pez-Moreno et al., 2021a</xref>).</p><p>A third area of relevance is antimicrobial resistance (AMR). Undoubtedly, AMR is an important OH issue, with the major contributor being the misuse of antibiotics (<xref rid="B83" ref-type="bibr">World Health Organization, 2015</xref>, <xref rid="B82" ref-type="bibr">2021</xref>; <xref rid="B49" ref-type="bibr">O&#x02019;Neill, 2016</xref>). Moreover, the GM has previously been considered as a reservoir for antibiotic resistance genes (<xref rid="B26" ref-type="bibr">Gibson et al., 2015</xref>; <xref rid="B5" ref-type="bibr">Anthony et al., 2021</xref>). Non-antibiotic antimicrobials, including MDCs triclosan and parabens, commonly used as preservatives in foods, food contact materials (FCMs) and personal care products (<xref rid="B69" ref-type="bibr">Soni et al., 2001</xref>, <xref rid="B71" ref-type="bibr">2002</xref>, <xref rid="B70" ref-type="bibr">2005</xref>; <xref rid="B18" ref-type="bibr">Cosmetic Ingredient Review Expert Panel, 2008</xref>; <xref rid="B28" ref-type="bibr">Halden et al., 2017</xref>), may also contribute to AMR (<xref rid="B64" ref-type="bibr">Scientific Committee on Consumer Safety [SCCS], 2010</xref>). This is because some resistance mechanisms are common to both biocidal MDCs and antibiotics, for example, the former may; exert selective stress leading to the expression of bacterial resistance mechanisms and their dissemination, and/or; maintain mobile genetic elements carrying genes involved in antibiotic cross-resistance (<xref rid="B65" ref-type="bibr">Scientific Committee on Emerging and Newly Identified Health Risks, 2009</xref>). Therefore, due to their detoxification potential certain GM taxa may become of particular interest in the context of such antimicrobials.</p><p>This perspective discusses these interlinked areas of relevance to the GM in the context of OH (<xref rid="F1" ref-type="fig">Figure 1</xref>). The first area relates primarily to human health. However, depending on the output of the RA and the antimicrobial or not nature of the xenobiotic, the other two areas are highly relevant to holistic xenobiotic risk management.</p><fig position="float" id="F1"><label>FIGURE 1</label><caption><p>Three interlinked areas of relevance to the human gut microbiome (GM) in the context of One Health (OH); incorporation of the GM in food safety risk assessment of xenobiotics; identification and application of beneficial GM taxa and components (e.g., enzymes and bioactive compounds) to various areas under OH, and; specifically, in the context of antimicrobial resistance. EDC, endocrine disrupting chemicals; MDC(s), microbiota disrupting chemicals.</p></caption><graphic xlink:href="fmicb-13-872583-g001" position="float"/></fig></sec><sec id="S2"><title>Incorporating the Gut Microbiome in Food Safety Risk Assessment of Xenobiotics Under One Health</title><p>GM variability adds layers of complexity to the already intricate interactions between MDCs and health. The observed differences in the GM have been attributed to multiple factors including age, antibiotic use, diet, disease state, environmental exposures, exercise, genetics, geography, pregnancy status, sex, socioeconomic status, and surgical interventions (<xref rid="B20" ref-type="bibr">Dethlefsen and Relman, 2011</xref>; <xref rid="B31" ref-type="bibr">Koren et al., 2012</xref>; <xref rid="B85" ref-type="bibr">Yatsunenko et al., 2012</xref>; <xref rid="B42" ref-type="bibr">Markle et al., 2013</xref>; <xref rid="B27" ref-type="bibr">Goodrich et al., 2014</xref>; <xref rid="B51" ref-type="bibr">O&#x02019;Sullivan et al., 2015</xref>; <xref rid="B76" ref-type="bibr">Tremaroli et al., 2015</xref>; <xref rid="B34" ref-type="bibr">Levin et al., 2016</xref>; <xref rid="B41" ref-type="bibr">Mar et al., 2016</xref>; <xref rid="B48" ref-type="bibr">National Academies of Sciences, Engineering, and Medicine [NASEM], 2018</xref>). Moreover, these factors may only explain a small fraction of the total GM variation (<xref rid="B22" ref-type="bibr">Falony et al., 2016</xref>; <xref rid="B17" ref-type="bibr">Comitato Nazionale per la Biosicurezza, le Biotecnologie e le Scienze della Vita [CNBBSV], 2019</xref>). Importantly, due to this variability, observations of microbiome-influenced toxicities in a studied population might have little relevance to other populations with substantially different GM composition and function (<xref rid="B61" ref-type="bibr">Rodricks et al., 2019</xref>).</p><p>In addition, there is considerable variation between the GMs of humans and animals, due to anatomical, physiological, functional, immunological and compositional differences. Some of these have been partially overcome via the use of &#x0201c;humanized&#x0201d; animals in toxicological studies (<xref rid="B72" ref-type="bibr">Sonnenburg and B&#x000e4;ckhed, 2016</xref>). Nevertheless, extrapolation from such studies to humans still carries considerable uncertainty (<xref rid="B61" ref-type="bibr">Rodricks et al., 2019</xref>) and, along with the intraspecies variability, necessitates the use of uncertainty/safety factors, frequently reaching two orders of magnitude (<xref rid="B21" ref-type="bibr">Dorne and Renwick, 2005</xref>; <xref rid="B10" ref-type="bibr">Benford et al., 2018</xref>). Based on these factors, traditional RAs may overestimate or underestimate the risk associated with exposure to an MDC, partially because they do not account for its interactions with the microbiome (<xref rid="B48" ref-type="bibr">National Academies of Sciences, Engineering, and Medicine [NASEM], 2018</xref>; <xref rid="B45" ref-type="bibr">Merten et al., 2020</xref>). Consequent risk management decisions may place considerable pressure on the industry. For example, EFSA&#x02019;s recent proposal to considerably reduce the tolerable daily intake for Bisphenol A (BPA) (<xref rid="B33" ref-type="bibr">Lambr&#x000e9; et al., 2022</xref>), may further increase the use of bisphenol analogs in FCMs, which may also trigger dysbiosis and obesogenic phenotypes (<xref rid="B4" ref-type="bibr">And&#x000fa;jar et al., 2019</xref>; <xref rid="B47" ref-type="bibr">Monteagudo et al., 2021</xref>).</p><p>Although the need is clear to incorporate the GM in the RA of xenobiotics, there are additional hurdles, i.e., the fundamental requirements to; establish causation and molecular mechanisms linking phenotypes, e.g., obesity, with microbiota profiles (<xref rid="B23" ref-type="bibr">Fischbach, 2018</xref>), and; define what constitutes a healthy GM, which still remains elusive (<xref rid="B45" ref-type="bibr">Merten et al., 2020</xref>). Considering that these tasks require significant resources, it might be a useful first step to establish principles on how to evaluate the potential of xenobiotics to alter the GM.</p><p>Interestingly, a three-tier framework has recently been proposed by the Unilever Safety and Environmental Assurance Center for assessing the potential of personal care formulations to perturb the skin and oral microbiomes (<xref rid="B46" ref-type="bibr">M&#x000e9;tris et al., 2021</xref>).</p><p>The first tier benchmarks new formulations against ones regarded as safe because of a long &#x0201c;history of safe use&#x0201d; (HoSU). However, this approach cannot apply directly to xenobiotics, for reasons such as their nature as contaminants or that they may not be intended to be ingested (e.g., if used in FCMs). Moreover, it is challenging to establish robust links between GM, cumulative exposure and resulting adverse effects (<xref rid="B50" ref-type="bibr">Ortiz et al., 2022</xref>). Nevertheless, evidence has been compiling in recent years on the impact of several contaminants and groups of xenobiotics, including pesticides, bisphenols, phthalates, metals, triclosan, parabens and polybrominated diphenyl ethers, on human and animal gut microbiomes (<xref rid="B2" ref-type="bibr">Aguilera et al., 2020</xref>). As it expands, this evidence could potentially serve as an early cross-reference tier which would raise initial concerns, depending on the nature and chemical structure of a xenobiotic under RA.</p><p>The second tier focuses on microbiome resilience. Other authors highlighted resilience, along with resistance to perturbation, as a key feature of healthy microbiomes, attributed to their rich and diverse metabolic pathways (<xref rid="B36" ref-type="bibr">Lloyd-Price et al., 2016</xref>; <xref rid="B44" ref-type="bibr">McBain et al., 2019</xref>; <xref rid="B14" ref-type="bibr">Cheng et al., 2022</xref>). Importantly, this tier assesses risk in relative terms. Thus, it circumvents the need to define the healthy microbiome, since it is only concerned about the return to its baseline state, independently of whether healthy or desirable. Of course, the length of exposure of the microbiome to the potential perturbator would be a critical consideration. Overall, however, this tier could be a reasonable approach to screen MDCs based on the resilience of the GM under various experimental approaches, extending from &#x0201c;humanized&#x0201d; animals (<xref rid="B48" ref-type="bibr">National Academies of Sciences, Engineering, and Medicine [NASEM], 2018</xref>) to <italic>ex vivo</italic> and <italic>in vitro</italic> models, such as simulator of the human intestinal microbial ecosystem (SHIME) (<xref rid="B80" ref-type="bibr">Van den Abbeele et al., 2012</xref>), minibioreactor arrays (<xref rid="B7" ref-type="bibr">Auchtung et al., 2015</xref>) and multi-compartment microfluidic-based gut-on-chip systems (<xref rid="B19" ref-type="bibr">De Gregorio et al., 2020</xref>; <xref rid="B68" ref-type="bibr">Signore et al., 2021</xref>).</p><p>Finally, the third tier makes use of next-generation sequencing microbiome data in relation to host health status. This requires further development, is the most challenging tier and is, certainly, relevant to the RA of xenobiotics in the context of the GM. <xref rid="B46" ref-type="bibr">M&#x000e9;tris et al. (2021)</xref> highlighted the importance of microbiome function over composition. This is not surprising, given that compositional variation might not necessarily impart key functional differences due to functional redundancy (<xref rid="B74" ref-type="bibr">Tian et al., 2020</xref>). Regarding research methodology, metatranscriptomics, is an established approach to focus on the functional taxa in the microbiome. More recent methodologies, however, have combined flow cytometry with omics technologies to characterize active microbial fractions in the GM, revealing a number of taxa underrepresented by traditional 16S rRNA metagenomics (<xref rid="B55" ref-type="bibr">Peris-Bondia et al., 2011</xref>; <xref rid="B43" ref-type="bibr">Maurice et al., 2013</xref>). These approaches are likely to offer valuable insights in the extrapolation of this tier&#x02019;s approach to the GM, especially in the pursuit for key species or other types of biomarkers associated with host health or disease, which will be crucial for the incorporation of the GM in the RA of MDCs.</p></sec><sec id="S3"><title>Identifying Beneficial Gut Microbiome Taxa and Other Components and Applying Them Under One Health</title><p>Taxa culturing strategies, in the context of the interactional triangle between EDCs (obesogens)-gut microbiota (dysbiosis vs. eubiosis)-human health (obesity vs. leanness), are key in obtaining and selecting strains (associated with pro-obesity and antiobesity phenotypes) with potential use as NGPs (<xref rid="B37" ref-type="bibr">L&#x000f3;pez-Moreno et al., 2021a</xref>). The latter, unlike traditional probiotics, do not have a defined HoSU, and are thus subjected to more stringent regulatory requirements (<xref rid="B52" ref-type="bibr">O&#x02019;Toole et al., 2017</xref>). Nevertheless, strains isolated from the human gut could more readily be used under OH, e.g., as probiotics for animals, plants, and environmental protection and bioremediation. Recent work has demonstrated that toxicomicrobiomics and culturomics are promising in exploring the potential of human GM taxa to metabolize obesogenic MDCs and selecting species able to tolerate or biodegrade BPA (<xref rid="B38" ref-type="bibr">L&#x000f3;pez-Moreno et al., 2021b</xref>,<xref rid="B39" ref-type="bibr">2022</xref>). Thus, similar approaches could be used going forward to explore the human GM as a source of beneficial microbes (NGPs), enzymes, and bioactive compounds linked to MDC detoxification or biodegradation, with various potential applications under OH (<xref rid="F1" ref-type="fig">Figure 1</xref>).</p></sec><sec id="S4"><title>Gut Microbiome and Antimicrobial Resistance Under One Health</title><p>MDCs, such as triclosan and parabens, contribute to the AMR issue, primarily through resistance development against themselves (self-resistance), but also potentially through development of cross-resistance against antibiotics (<xref rid="B59" ref-type="bibr">Ribado et al., 2017</xref>). Although the evidence supporting cross-resistance development <italic>in situ</italic> is not conclusive (<xref rid="B64" ref-type="bibr">Scientific Committee on Consumer Safety [SCCS], 2010</xref>), the potential contribution of MDCs to AMR and their mechanisms merit further data compilation (<xref rid="B79" ref-type="bibr">Valkova et al., 2002</xref>; <xref rid="B29" ref-type="bibr">Hughes et al., 2020</xref>; <xref rid="B62" ref-type="bibr">Rozman et al., 2021</xref>). Moreover, given that antimicrobial MDCs would likely have higher potential to alter and perturb microbiomes (compared to non-antimicrobial xenobiotics), they have been proposed as candidate chemicals in investigations that would built our understanding around the xenobiotic-microbiome interactions in the context of xenobiotic RA (<xref rid="B48" ref-type="bibr">National Academies of Sciences, Engineering, and Medicine [NASEM], 2018</xref>).</p><p>Nevertheless, even non-antimicrobial xenobiotics may pose resistance development issues in the context of the GM, as exposure to them may apply a selective pressure in favor of microbial taxa with specific enzymatic arsenals and metabolic pathways. For example, <xref rid="B39" ref-type="bibr">L&#x000f3;pez-Moreno et al. (2022)</xref>, associated BPA exposure and the obese phenotype in children to higher BPA biodegradation potential in their GM. Moreover, they reported that BPA-resistant strains isolated from human gut microbiota exhibited xenobiotic biodegradation and antimicrobial effects linked to polyketide biosynthesis (<xref rid="B75" ref-type="bibr">Torres-S&#x000e1;nchez et al., 2021</xref>). Therefore, in the presence of BPA, these strains may further modulate the composition and function of the human gut microbiota, potentially reducing GM diversity and inducing dysbiosis and adverse metabolic effects (<xref rid="B2" ref-type="bibr">Aguilera et al., 2020</xref>). The mechanisms, via which gut microbiome taxa may be affected by non-antibacterial MDCs, potentially leading to dysbiosis, could include growth inhibition or promotion and metabolism modulation (<xref rid="B35" ref-type="bibr">Lindell et al., 2022</xref>). For example, several artificial sweeteners, spice extracts and food dyes have been shown to inhibit the growth of specific bacterial strains <italic>in vivo</italic>, while certain natural xenobiotics and food additives appear to promote the growth of other strains under similar conditions, likely acting as nutrient sources (<xref rid="B53" ref-type="bibr">Pan et al., 2012</xref>; <xref rid="B9" ref-type="bibr">Bello Gonz&#x000e1;lez et al., 2016</xref>; <xref rid="B40" ref-type="bibr">Lu et al., 2017</xref>; <xref rid="B81" ref-type="bibr">Wang et al., 2018</xref>; <xref rid="B63" ref-type="bibr">Ruiz-Ojeda et al., 2019</xref>; <xref rid="B24" ref-type="bibr">Frame et al., 2020</xref>). Additionally, an alkaloid found naturally in coffee, trigonelline, has shown potential to alter the metabolism of a common human gut commensal <italic>in vivo</italic> (<xref rid="B6" ref-type="bibr">Anwar et al., 2018</xref>). Although limited, this evidence suggests that the potential for xenobiotic resistance development, in the context of the GM, may warrant further consideration and research, beyond antimicrobial resistance.</p><p>Overall, applying GM taxa and biocompounds able to metabolize antimicrobial MDCs to crosscutting areas under OH could potentially ameliorate AMR pressure (<xref rid="F1" ref-type="fig">Figure 1</xref>).</p></sec><sec sec-type="conclusion" id="S5"><title>Conclusions</title><list list-type="simple"><list-item><label>&#x02022;</label><p>Focusing on the GM&#x02019;s resilience circumvents some of the RA challenges. Moreover, looking at function, rather than composition, and exploring the active components of the GM can help establish specific biomarkers, necessary for incorporating the GM in the RA of xenobiotics.</p></list-item><list-item><label>&#x02022;</label><p>The human GM may be a promising source of beneficial microbes (i.e., probiotics, NGPs and biodegraders), enzymes, and bioactive compounds, with the potential to metabolize xenobiotics. These may have potential applications in various areas under OH.</p></list-item><list-item><label>&#x02022;</label><p>Applying human GM components, able to metabolize antimicrobial MDCs under OH could also help ameliorate the global risk of AMR development.</p></list-item><list-item><label>&#x02022;</label><p>The potential for xenobiotic resistance development, in the context of the GM, may warrant further consideration.</p></list-item></list></sec><sec sec-type="data-availability" id="S6"><title>Data Availability Statement</title><p>The original contributions presented in this perspective are included in the article; further inquiries can be directed to the corresponding authors.</p></sec><sec id="S7"><title>Author Contributions</title><p>AA: conceptualization, original draft preparation, review, and editing. MA: conceptualization, review, and editing. AG-K, AT-S, AL-M, KC, PO, and MM-S: review and editing. All authors have read and agreed to the published version of the manuscript.</p></sec><sec sec-type="COI-statement" id="conf1"><title>Conflict of Interest</title><p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></sec><sec sec-type="disclaimer" id="pudiscl1"><title>Publisher&#x02019;s Note</title><p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p></sec></body><back><sec sec-type="funding-information" id="S8"><title>Funding</title><p>This work was supported by the EU-FORA Program (Cycle 2020/2021 and 2021/2022). This work was carried out within the frame of FEDER-Microbiota Infrastructure: IE19_198 UGR, OBEMIRISK EFSA-Partnering Grant GP/EFSA/ENCO/2018/03-GA04, and Europa Investigaci&#x000f3;n EIN2019-103082. The authors belong to BIO190 Group Junta de Andalucia and Plan Propio (University of Granada).</p></sec><ref-list><title>References</title><ref id="B1"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abdelsalam</surname><given-names>N. A.</given-names></name><name><surname>Ramadan</surname><given-names>A. T.</given-names></name><name><surname>ElRakaiby</surname><given-names>M. T.</given-names></name><name><surname>Aziz</surname><given-names>R. K.</given-names></name></person-group> (<year>2020</year>). <article-title>Toxicomicrobiomics: the human microbiome vs. pharmaceutical, dietary, and environmental xenobiotics.</article-title>
<source><italic>Front. Pharmacol.</italic></source>
<volume>11</volume>:<issue>390</issue>. <pub-id pub-id-type="doi">10.3389/fphar.2020.00390</pub-id>
<?supplied-pmid 32372951?><pub-id pub-id-type="pmid">32372951</pub-id></mixed-citation></ref><ref id="B2"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aguilera</surname><given-names>M.</given-names></name><name><surname>G&#x000e1;lvez-Ontiveros</surname><given-names>Y.</given-names></name><name><surname>Rivas</surname><given-names>A.</given-names></name></person-group> (<year>2020</year>). <article-title>Endobolome, a new concept for determining the influence of microbiota disrupting chemicals (MDC) in relation to specific endocrine pathogenesis.</article-title>
<source><italic>Front. Microbiol.</italic></source>
<volume>11</volume>:<issue>578007</issue>. <pub-id pub-id-type="doi">10.3389/fmicb.2020.578007</pub-id>
<?supplied-pmid 33329442?><pub-id pub-id-type="pmid">33329442</pub-id></mixed-citation></ref><ref id="B3"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aguilera</surname><given-names>M.</given-names></name><name><surname>Lamas</surname><given-names>B.</given-names></name><name><surname>Van Pamel</surname><given-names>E.</given-names></name><name><surname>Bhide</surname><given-names>M.</given-names></name><name><surname>Houdeau</surname><given-names>E.</given-names></name><name><surname>Rivas</surname><given-names>A.</given-names></name></person-group> (<year>2021</year>). <article-title>Editorial: risk of dietary hazardous substances and impact on human microbiota: possible role in several dysbiosis phenotypes.</article-title>
<source><italic>Front. Microbiol.</italic></source>
<volume>12</volume>:<issue>669480</issue>. <pub-id pub-id-type="doi">10.3389/fmicb.2021.669480</pub-id>
<?supplied-pmid 33968005?><pub-id pub-id-type="pmid">33968005</pub-id></mixed-citation></ref><ref id="B4"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>And&#x000fa;jar</surname><given-names>N.</given-names></name><name><surname>G&#x000e1;lvez-Ontiveros</surname><given-names>Y.</given-names></name><name><surname>Zafra-G&#x000f3;mez</surname><given-names>A.</given-names></name><name><surname>Rodrigo</surname><given-names>L.</given-names></name><name><surname>&#x000c1;lvarez-Cubero, Aguilera</surname><given-names>M.</given-names></name><etal/></person-group> (<year>2019</year>). <article-title>Bisphenol a analogues in food and their hormonal and obesogenic effects: a review.</article-title>
<source><italic>Nutrients</italic></source>
<volume>11</volume>:<issue>2136</issue>. <pub-id pub-id-type="doi">10.3390/nu11092136</pub-id>
<?supplied-pmid 31500194?><pub-id pub-id-type="pmid">31500194</pub-id></mixed-citation></ref><ref id="B5"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anthony</surname><given-names>W. E.</given-names></name><name><surname>Burnham</surname><given-names>C.-A. D.</given-names></name><name><surname>Dantas</surname><given-names>G.</given-names></name><name><surname>Kwon</surname><given-names>J. H.</given-names></name></person-group> (<year>2021</year>). <article-title>The gut microbiome as a reservoir for antimicrobial resistance.</article-title>
<source><italic>J. Infect. Dis.</italic></source>
<volume>223</volume>:<fpage>S209</fpage>&#x02013;<lpage>S213</lpage>. <pub-id pub-id-type="doi">10.1093/infdis/jiaa497</pub-id>
<?supplied-pmid 33326581?><pub-id pub-id-type="pmid">33326581</pub-id></mixed-citation></ref><ref id="B6"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anwar</surname><given-names>S.</given-names></name><name><surname>Bhandari</surname><given-names>U.</given-names></name><name><surname>Panda</surname><given-names>B. P.</given-names></name><name><surname>Dubey</surname><given-names>K.</given-names></name><name><surname>Khan</surname><given-names>W.</given-names></name><name><surname>Ahmad</surname><given-names>S.</given-names></name></person-group> (<year>2018</year>). <article-title>Trigonelline inhibits intestinal microbial metabolism of choline and its associated cardiovascular risk.</article-title>
<source><italic>J. Pharm. Biomed. Anal.</italic></source>
<volume>159</volume>
<fpage>100</fpage>&#x02013;<lpage>112</lpage>. <pub-id pub-id-type="doi">10.1016/j.jpba.2018.06.027</pub-id>
<?supplied-pmid 29980011?><pub-id pub-id-type="pmid">29980011</pub-id></mixed-citation></ref><ref id="B7"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Auchtung</surname><given-names>J. M.</given-names></name><name><surname>Robinson</surname><given-names>C. D.</given-names></name><name><surname>Britton</surname><given-names>R. A.</given-names></name></person-group> (<year>2015</year>). <article-title>Cultivation of stable, reproducible microbial communities from different fecal donors using minibioreactor arrays (MBRAs).</article-title>
<source><italic>Microbiome</italic></source>
<volume>3</volume>:<issue>42</issue>. <pub-id pub-id-type="doi">10.1186/s40168-015-0106-5</pub-id>
<?supplied-pmid 26419531?><pub-id pub-id-type="pmid">26419531</pub-id></mixed-citation></ref><ref id="B8"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aziz</surname><given-names>R. K.</given-names></name></person-group> (<year>2018</year>). <article-title>Toxicomicrobiomics: narrowing the gap between environmental and medicinal toxicogenomics.</article-title>
<source><italic>OMICS J. Integr. Biol.</italic></source>
<volume>22</volume>
<fpage>788</fpage>&#x02013;<lpage>789</lpage>. <pub-id pub-id-type="doi">10.1089/omi.2018.0183</pub-id>
<?supplied-pmid 30571608?><pub-id pub-id-type="pmid">30571608</pub-id></mixed-citation></ref><ref id="B9"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bello Gonz&#x000e1;lez</surname><given-names>T.</given-names></name><name><surname>de</surname><given-names>J.</given-names></name><name><surname>Zuidema</surname><given-names>T.</given-names></name><name><surname>Bor</surname><given-names>G.</given-names></name><name><surname>Smidt</surname><given-names>H.</given-names></name><name><surname>van Passel</surname><given-names>M. W. J.</given-names></name></person-group> (<year>2016</year>). <article-title>Study of the aminoglycoside subsistence phenotype of bacteria residing in the gut of humans and zoo animals.</article-title>
<source><italic>Front. Microbiol</italic></source>
<volume>6</volume>:<issue>1550</issue>. <pub-id pub-id-type="doi">10.3389/fmicb.2015.01550</pub-id>
<?supplied-pmid 26793182?><pub-id pub-id-type="pmid">26793182</pub-id></mixed-citation></ref><ref id="B10"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Benford</surname><given-names>D.</given-names></name><name><surname>Halldorsson</surname><given-names>T.</given-names></name><name><surname>Jeger</surname><given-names>M. J.</given-names></name><name><surname>Knutsen</surname><given-names>H. K.</given-names></name><name><surname>More</surname><given-names>S.</given-names></name><name><surname>Naegeli</surname><given-names>H.</given-names></name><etal/></person-group> (<year>2018</year>). <article-title>Guidance on uncertainty analysis in scientific assessments.</article-title>
<source><italic>EFSA J.</italic></source>
<volume>16</volume>:<issue>5123</issue>. <pub-id pub-id-type="doi">10.2903/j.efsa.2018.5123</pub-id>
<?supplied-pmid 32625671?><pub-id pub-id-type="pmid">32625671</pub-id></mixed-citation></ref><ref id="B11"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berg</surname><given-names>G.</given-names></name><name><surname>Rybakova</surname><given-names>D.</given-names></name><name><surname>Fischer</surname><given-names>D.</given-names></name><name><surname>Cernava</surname><given-names>T.</given-names></name><name><surname>Verg&#x000e8;s</surname><given-names>M.-C. C.</given-names></name><name><surname>Charles</surname><given-names>T.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>Microbiome definition re-visited: old concepts and new challenges.</article-title>
<source><italic>Microbiome</italic></source>
<volume>8</volume>:<issue>103</issue>. <pub-id pub-id-type="doi">10.1186/s40168-020-00875-0</pub-id>
<?supplied-pmid 32605663?><pub-id pub-id-type="pmid">32605663</pub-id></mixed-citation></ref><ref id="B12"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bronzwaer</surname><given-names>S.</given-names></name><name><surname>Geervliet</surname><given-names>M.</given-names></name><name><surname>Hugas</surname><given-names>M.</given-names></name><name><surname>Url</surname><given-names>B.</given-names></name></person-group> (<year>2021</year>). <article-title>EFSA&#x02019;s expertise supports one health policy needs.</article-title>
<source><italic>EFSA J.</italic></source>
<volume>19</volume>:<issue>e190501</issue>. <pub-id pub-id-type="doi">10.2903/j.efsa.2021.e190501</pub-id>
<?supplied-pmid 34012492?><pub-id pub-id-type="pmid">34012492</pub-id></mixed-citation></ref><ref id="B13"><mixed-citation publication-type="journal"><collab>Centers for Disease Control and Prevention</collab> (<year>2020</year>). <source><italic>One Health Basics. One Health.</italic></source> Available Online at URL <ext-link xlink:href="https://www.cdc.gov/onehealth/basics/index.html" ext-link-type="uri">https://www.cdc.gov/onehealth/basics/index.html</ext-link>
<comment>(accessed Janauary.19.22)</comment></mixed-citation></ref><ref id="B14"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheng</surname><given-names>M.</given-names></name><name><surname>Liu</surname><given-names>H.</given-names></name><name><surname>Han</surname><given-names>M.</given-names></name><name><surname>Li</surname><given-names>S. C.</given-names></name><name><surname>Bu</surname><given-names>D.</given-names></name><name><surname>Sun</surname><given-names>S.</given-names></name><etal/></person-group> (<year>2022</year>). <article-title>Microbiome resilience and health implications for people in half-year travel.</article-title>
<source><italic>Front. Immunol.</italic></source>
<volume>24</volume>:<issue>848994</issue>. <pub-id pub-id-type="doi">10.3389/fimmu.2022.848994</pub-id>
<?supplied-pmid 35281043?><pub-id pub-id-type="pmid">35281043</pub-id></mixed-citation></ref><ref id="B15"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Claus</surname><given-names>S. P.</given-names></name><name><surname>Guillou</surname><given-names>H.</given-names></name><name><surname>Ellero-Simatos</surname><given-names>S.</given-names></name></person-group> (<year>2016</year>). <article-title>The gut microbiota: a major player in the toxicity of environmental pollutants?</article-title>
<source><italic>Npj Biofilms Microbiomes</italic></source>
<volume>2</volume>
<fpage>1</fpage>&#x02013;<lpage>11</lpage>. <pub-id pub-id-type="doi">10.1038/npjbiofilms.2016.3</pub-id>
<?supplied-pmid 28721242?><pub-id pub-id-type="pmid">28649395</pub-id></mixed-citation></ref><ref id="B16"><mixed-citation publication-type="book"><collab>Codex Alimentarius Commission</collab> (<year>1999</year>). <source><italic>Principles and Guidelines for the Conduct of Microbiological Risk Assessment CAC/GL 30-1999.</italic></source>
<publisher-loc>Rome</publisher-loc>: <publisher-name>Codex Alimentarius Commission</publisher-name>.</mixed-citation></ref><ref id="B17"><mixed-citation publication-type="book"><collab>Comitato Nazionale per la Biosicurezza, le Biotecnologie e le Scienze della Vita [CNBBSV]</collab> (<year>2019</year>). <source><italic>Concept paper. Italian Microbiome Initiative for Improved Human Health and Agri-Food Production. Presidenza Del Consiglio Dei Ministri Comitato Nazionale Per La Biosicurezza, le Biotecnologie e le Scienze Della Vita.</italic></source>
<publisher-loc>Rome</publisher-loc>: <publisher-name>CNBBSV</publisher-name>.</mixed-citation></ref><ref id="B18"><mixed-citation publication-type="journal"><collab>Cosmetic Ingredient Review Expert Panel</collab> (<year>2008</year>). <article-title>Final amended report on the safety assessment of methylparaben, ethylparaben, propylparaben, isopropylparaben, butylparaben, isobutylparaben, and benzylparaben as used in cosmetic products.</article-title>
<source><italic>Int. J. Toxicol.</italic></source>
<volume>27</volume>(<issue>Suppl. 4</issue>), <fpage>1</fpage>&#x02013;<lpage>82</lpage>. <pub-id pub-id-type="doi">10.1080/10915810802548359</pub-id>
<?supplied-pmid 19101832?><pub-id pub-id-type="pmid">19101832</pub-id></mixed-citation></ref><ref id="B19"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Gregorio</surname><given-names>V.</given-names></name><name><surname>Telesco</surname><given-names>M.</given-names></name><name><surname>Corrado</surname><given-names>B.</given-names></name><name><surname>Rosiello</surname><given-names>V.</given-names></name><name><surname>Urciuolo</surname><given-names>F.</given-names></name><name><surname>Netti</surname><given-names>P. A.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>Intestine-liver axis on-chip reveals the intestinal protective role on hepatic damage by emulating ethanol first-pass metabolism.</article-title>
<source><italic>Front. Bioeng. Biotechnol.</italic></source>
<volume>8</volume>:<issue>163</issue>. <pub-id pub-id-type="doi">10.3389/fbioe.2020.00163</pub-id>
<?supplied-pmid 32258006?><pub-id pub-id-type="pmid">32258006</pub-id></mixed-citation></ref><ref id="B20"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dethlefsen</surname><given-names>L.</given-names></name><name><surname>Relman</surname><given-names>D. A.</given-names></name></person-group> (<year>2011</year>). <article-title>Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation.</article-title>
<source><italic>Proc. Natl. Acad. Sci.</italic></source>
<volume>108</volume>
<fpage>4554</fpage>&#x02013;<lpage>4561</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1000087107</pub-id>
<?supplied-pmid 20847294?><pub-id pub-id-type="pmid">20847294</pub-id></mixed-citation></ref><ref id="B21"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dorne</surname><given-names>J. L. C. M.</given-names></name><name><surname>Renwick</surname><given-names>A. G.</given-names></name></person-group> (<year>2005</year>). <article-title>The refinement of uncertainty/safety factors in risk assessment by the incorporation of data on toxicokinetic variability in humans.</article-title>
<source><italic>Toxicol. Sci. Off. J. Soc. Toxicol.</italic></source>
<volume>86</volume>
<fpage>20</fpage>&#x02013;<lpage>26</lpage>. <pub-id pub-id-type="doi">10.1093/toxsci/kfi160</pub-id>
<?supplied-pmid 15800035?><pub-id pub-id-type="pmid">15800035</pub-id></mixed-citation></ref><ref id="B22"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Falony</surname><given-names>G.</given-names></name><name><surname>Joossens</surname><given-names>M.</given-names></name><name><surname>Vieira-Silva</surname><given-names>S.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Darzi</surname><given-names>Y.</given-names></name><name><surname>Faust</surname><given-names>K.</given-names></name><etal/></person-group> (<year>2016</year>). <article-title>Population-level analysis of gut microbiome variation.</article-title>
<source><italic>Science</italic></source>
<volume>352</volume>
<fpage>560</fpage>&#x02013;<lpage>564</lpage>. <pub-id pub-id-type="doi">10.1126/science.aad3503</pub-id>
<?supplied-pmid 27126039?><pub-id pub-id-type="pmid">27126039</pub-id></mixed-citation></ref><ref id="B23"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fischbach</surname><given-names>M. A.</given-names></name></person-group> (<year>2018</year>). <article-title>Microbiome: focus on causation and mechanism.</article-title>
<source><italic>Cell</italic></source>
<volume>174</volume>
<fpage>785</fpage>&#x02013;<lpage>790</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2018.07.038</pub-id>
<?supplied-pmid 30096310?><pub-id pub-id-type="pmid">30096310</pub-id></mixed-citation></ref><ref id="B24"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frame</surname><given-names>L. A.</given-names></name><name><surname>Costa</surname><given-names>E.</given-names></name><name><surname>Jackson</surname><given-names>S. A.</given-names></name></person-group> (<year>2020</year>). <article-title>Current explorations of nutrition and the gut microbiome: a comprehensive evaluation of the review literature.</article-title>
<source><italic>Nutr. Rev.</italic></source>
<volume>78</volume>
<fpage>798</fpage>&#x02013;<lpage>812</lpage>. <pub-id pub-id-type="doi">10.1093/nutrit/nuz106</pub-id>
<?supplied-pmid 32211860?><pub-id pub-id-type="pmid">32211860</pub-id></mixed-citation></ref><ref id="B25"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>G&#x000e1;lvez-Ontiveros</surname><given-names>Y.</given-names></name><name><surname>P&#x000e1;ez</surname><given-names>S.</given-names></name><name><surname>Monteagudo</surname><given-names>C.</given-names></name><name><surname>Rivas</surname><given-names>A.</given-names></name></person-group> (<year>2020</year>). <article-title>Endocrine disruptors in food: impact on gut microbiota and metabolic diseases.</article-title>
<source><italic>Nutrients</italic></source>
<volume>12</volume>:<issue>1158</issue>. <pub-id pub-id-type="doi">10.3390/nu12041158</pub-id>
<?supplied-pmid 32326280?><pub-id pub-id-type="pmid">32326280</pub-id></mixed-citation></ref><ref id="B26"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gibson</surname><given-names>M. K.</given-names></name><name><surname>Crofts</surname><given-names>T. S.</given-names></name><name><surname>Dantas</surname><given-names>G.</given-names></name></person-group> (<year>2015</year>). <article-title>Antibiotics and the developing infant gut microbiota and resistome.</article-title>
<source><italic>Curr. Opin. Microbiol.</italic></source>
<volume>27</volume>
<fpage>51</fpage>&#x02013;<lpage>56</lpage>. <pub-id pub-id-type="doi">10.1016/j.mib.2015.07.007</pub-id>
<?supplied-pmid 26241507?><pub-id pub-id-type="pmid">26241507</pub-id></mixed-citation></ref><ref id="B27"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goodrich</surname><given-names>J. K.</given-names></name><name><surname>Waters</surname><given-names>J. L.</given-names></name><name><surname>Poole</surname><given-names>A. C.</given-names></name><name><surname>Sutter</surname><given-names>J. L.</given-names></name><name><surname>Koren</surname><given-names>O.</given-names></name><name><surname>Blekhman</surname><given-names>R.</given-names></name><etal/></person-group> (<year>2014</year>). <article-title>Human genetics shape the gut microbiome.</article-title>
<source><italic>Cell</italic></source>
<volume>159</volume>
<fpage>789</fpage>&#x02013;<lpage>799</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2014.09.053</pub-id>
<?supplied-pmid 25417156?><pub-id pub-id-type="pmid">25417156</pub-id></mixed-citation></ref><ref id="B28"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Halden</surname><given-names>R. U.</given-names></name><name><surname>Lindeman</surname><given-names>A. E.</given-names></name><name><surname>Aiello</surname><given-names>A. E.</given-names></name><name><surname>Andrews</surname><given-names>D.</given-names></name><name><surname>Arnold</surname><given-names>W. A.</given-names></name><name><surname>Fair</surname><given-names>P.</given-names></name><etal/></person-group> (<year>2017</year>). <article-title>The florence statement on triclosan and triclocarban.</article-title>
<source><italic>Environ. Health Perspect.</italic></source>
<volume>125</volume>:<issue>064501</issue>. <pub-id pub-id-type="doi">10.1289/EHP1788</pub-id>
<?supplied-pmid 28632490?><pub-id pub-id-type="pmid">28632490</pub-id></mixed-citation></ref><ref id="B29"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hughes</surname><given-names>L.</given-names></name><name><surname>Roberts</surname><given-names>W.</given-names></name><name><surname>Johnson</surname><given-names>D.</given-names></name></person-group> (<year>2020</year>). <article-title>The impact of DNA adenine methyltransferase knockout on the development of triclosan resistance and antibiotic cross-resistance in <italic>Escherichia coli</italic>.</article-title>
<source><italic>Access Microbiol.</italic></source>
<volume>3</volume>:<issue>acmi000178</issue>. <pub-id pub-id-type="doi">10.1099/acmi.0.000178</pub-id>
<?supplied-pmid 33997609?><pub-id pub-id-type="pmid">33997609</pub-id></mixed-citation></ref><ref id="B30"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kelly</surname><given-names>J.</given-names></name><name><surname>Kennedy</surname><given-names>P.</given-names></name><name><surname>Cryan</surname><given-names>J.</given-names></name><name><surname>Dinan</surname><given-names>T.</given-names></name><name><surname>Clarke</surname><given-names>G.</given-names></name><name><surname>Hyland</surname><given-names>N.</given-names></name></person-group> (<year>2015</year>). <article-title>Breaking down the barriers: the gut microbiome, intestinal permeability and stress-related psychiatric disorders.</article-title>
<source><italic>Front. Cell. Neurosci.</italic></source>
<volume>9</volume>:<issue>392</issue>. <pub-id pub-id-type="doi">10.3389/fncel.2015.00392</pub-id>
<?supplied-pmid 26528128?><pub-id pub-id-type="pmid">26528128</pub-id></mixed-citation></ref><ref id="B31"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koren</surname><given-names>O.</given-names></name><name><surname>Goodrich</surname><given-names>J. K.</given-names></name><name><surname>Cullender</surname><given-names>T. C.</given-names></name><name><surname>Spor</surname><given-names>A.</given-names></name><name><surname>Laitinen</surname><given-names>K.</given-names></name><name><surname>Kling B&#x000e4;ckhed</surname><given-names>H.</given-names></name><etal/></person-group> (<year>2012</year>). <article-title>Host remodeling of the gut microbiome and metabolic changes during pregnancy.</article-title>
<source><italic>Cell</italic></source>
<volume>150</volume>
<fpage>470</fpage>&#x02013;<lpage>480</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2012.07.008</pub-id>
<?supplied-pmid 22863002?><pub-id pub-id-type="pmid">22863002</pub-id></mixed-citation></ref><ref id="B32"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lagier</surname><given-names>J.-C.</given-names></name><name><surname>Dubourg</surname><given-names>G.</given-names></name><name><surname>Million</surname><given-names>M.</given-names></name><name><surname>Cadoret</surname><given-names>F.</given-names></name><name><surname>Bilen</surname><given-names>M.</given-names></name><name><surname>Fenollar</surname><given-names>F.</given-names></name><etal/></person-group> (<year>2018</year>). <article-title>Culturing the human microbiota and culturomics.</article-title>
<source><italic>Nat. Rev. Microbiol.</italic></source>
<volume>16</volume>
<fpage>540</fpage>&#x02013;<lpage>550</lpage>. <pub-id pub-id-type="doi">10.1038/s41579-018-0041-0</pub-id>
<?supplied-pmid 29937540?><pub-id pub-id-type="pmid">29937540</pub-id></mixed-citation></ref><ref id="B33"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lambr&#x000e9;</surname><given-names>C.</given-names></name><name><surname>Baviera</surname><given-names>J. M. B.</given-names></name><name><surname>Bolognesi</surname><given-names>C.</given-names></name><name><surname>Chesson</surname><given-names>A.</given-names></name><name><surname>Cocconcelli</surname><given-names>P. S.</given-names></name><name><surname>Crebelli</surname><given-names>R.</given-names></name><etal/></person-group> (<year>2022</year>). <article-title>Draft scientific opinion of EFSA panel on food contact materials, enzymes and processing aids (CEP): re-evaluation of the risks to public health related to the presence of bisphenol A (BPA) in foodstuffs</article-title>. <source><italic>EFSA J.</italic></source> [<comment>Preprint</comment>].</mixed-citation></ref><ref id="B34"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Levin</surname><given-names>A. M.</given-names></name><name><surname>Sitarik</surname><given-names>A. R.</given-names></name><name><surname>Havstad</surname><given-names>S. L.</given-names></name><name><surname>Fujimura</surname><given-names>K. E.</given-names></name><name><surname>Wegienka</surname><given-names>G.</given-names></name><name><surname>Cassidy-Bushrow</surname><given-names>A. E.</given-names></name><etal/></person-group> (<year>2016</year>). <article-title>Joint effects of pregnancy, sociocultural, and environmental factors on early life gut microbiome structure and diversity.</article-title>
<source><italic>Sci. Rep.</italic></source>
<volume>6</volume>:<issue>31775</issue>. <pub-id pub-id-type="doi">10.1038/srep31775</pub-id>
<?supplied-pmid 27558272?><pub-id pub-id-type="pmid">27558272</pub-id></mixed-citation></ref><ref id="B35"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lindell</surname><given-names>A. E.</given-names></name><name><surname>Zimmermann-Kogadeeva</surname><given-names>M.</given-names></name><name><surname>Patil</surname><given-names>K. R.</given-names></name></person-group> (<year>2022</year>). <article-title>Multimodal interactions of drugs, natural compounds and pollutants with the gut microbiota.</article-title>
<source><italic>Nat. Rev. Microbiol.</italic></source>
<fpage>1</fpage>&#x02013;<lpage>13</lpage>. <pub-id pub-id-type="doi">10.1038/s41579-022-00681-5</pub-id>
<?supplied-pmid 35102308?><pub-id pub-id-type="pmid">35102308</pub-id></mixed-citation></ref><ref id="B36"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lloyd-Price</surname><given-names>J.</given-names></name><name><surname>Abu-Ali</surname><given-names>G.</given-names></name><name><surname>Huttenhower</surname><given-names>C.</given-names></name></person-group> (<year>2016</year>). <article-title>The healthy human microbiome.</article-title>
<source><italic>Genome Med.</italic></source>
<volume>8</volume>:<issue>51</issue>. <pub-id pub-id-type="doi">10.1186/s13073-016-0307-y</pub-id>
<?supplied-pmid 27122046?><pub-id pub-id-type="pmid">27122046</pub-id></mixed-citation></ref><ref id="B37"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>L&#x000f3;pez-Moreno</surname><given-names>A.</given-names></name><name><surname>Acu&#x000f1;a</surname><given-names>I.</given-names></name><name><surname>Torres-S&#x000e1;nchez</surname><given-names>A.</given-names></name><name><surname>Ruiz-Moreno</surname><given-names>&#x000c1;</given-names></name><name><surname>Cerk</surname><given-names>K.</given-names></name><name><surname>Rivas</surname><given-names>A.</given-names></name><etal/></person-group> (<year>2021a</year>). <article-title>Next generation probiotics for neutralizing obesogenic effects: taxa culturing searching strategies.</article-title>
<source><italic>Nutrients</italic></source>
<volume>13</volume>:<issue>1617</issue>. <pub-id pub-id-type="doi">10.3390/nu13051617</pub-id>
<?supplied-pmid 34065873?><pub-id pub-id-type="pmid">34065873</pub-id></mixed-citation></ref><ref id="B38"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>L&#x000f3;pez-Moreno</surname><given-names>A.</given-names></name><name><surname>Torres-S&#x000e1;nchez</surname><given-names>A.</given-names></name><name><surname>Acu&#x000f1;a</surname><given-names>I.</given-names></name><name><surname>Su&#x000e1;rez</surname><given-names>A.</given-names></name><name><surname>Aguilera</surname><given-names>M.</given-names></name></person-group> (<year>2021b</year>). <article-title>Representative <italic>Bacillus</italic> sp. AM1 from Gut Microbiota Harbor Versatile Molecular Pathways for Bisphenol A Biodegradation.</article-title>
<source><italic>Int. J. Mol. Sci.</italic></source>
<volume>22</volume>:<issue>4952</issue>. <pub-id pub-id-type="doi">10.3390/ijms22094952</pub-id>
<?supplied-pmid 34066922?><pub-id pub-id-type="pmid">34066922</pub-id></mixed-citation></ref><ref id="B39"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>L&#x000f3;pez-Moreno</surname><given-names>A.</given-names></name><name><surname>Ruiz-Moreno</surname><given-names>&#x000c1;</given-names></name><name><surname>Pardo-Cacho</surname><given-names>J.</given-names></name><name><surname>Cerk</surname><given-names>K.</given-names></name><name><surname>Torres-S&#x000e1;nchez</surname><given-names>A.</given-names></name><name><surname>Ortiz</surname><given-names>P.</given-names></name><etal/></person-group> (<year>2022</year>). <article-title>Culturing and molecular approaches for identifying microbiota taxa impacting children&#x02019;s obesogenic phenotypes related to xenobiotic dietary exposure.</article-title>
<source><italic>Nutrients</italic></source>
<volume>14</volume>:<issue>241</issue>. <pub-id pub-id-type="doi">10.3390/nu14020241</pub-id>
<?supplied-pmid 35057422?><pub-id pub-id-type="pmid">35057422</pub-id></mixed-citation></ref><ref id="B40"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>Q.-Y.</given-names></name><name><surname>Summanen</surname><given-names>P. H.</given-names></name><name><surname>Lee</surname><given-names>R.-P.</given-names></name><name><surname>Huang</surname><given-names>J.</given-names></name><name><surname>Henning</surname><given-names>S. M.</given-names></name><name><surname>Heber</surname><given-names>D.</given-names></name><etal/></person-group> (<year>2017</year>). <article-title>Prebiotic potential and chemical composition of seven culinary spice extracts.</article-title>
<source><italic>J. Food Sci.</italic></source>
<volume>82</volume>
<fpage>1807</fpage>&#x02013;<lpage>1813</lpage>. <pub-id pub-id-type="doi">10.1111/1750-3841.13792</pub-id>
<?supplied-pmid 28678344?><pub-id pub-id-type="pmid">28678344</pub-id></mixed-citation></ref><ref id="B41"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mar</surname><given-names>J. S.</given-names></name><name><surname>LaMere</surname><given-names>B. J.</given-names></name><name><surname>Lin</surname><given-names>D. L.</given-names></name><name><surname>Levan</surname><given-names>S.</given-names></name><name><surname>Nazareth</surname><given-names>M.</given-names></name><name><surname>Mahadevan</surname><given-names>U.</given-names></name><etal/></person-group> (<year>2016</year>). <article-title>Disease severity and immune activity relate to distinct interkingdom gut microbiome states in ethnically distinct ulcerative colitis patients.</article-title>
<source><italic>mBio</italic></source>
<volume>7</volume>:<fpage>e1072</fpage>&#x02013;<lpage>e1016</lpage>. <pub-id pub-id-type="doi">10.1128/mBio.01072-16</pub-id>
<?supplied-pmid 27531910?><pub-id pub-id-type="pmid">27531910</pub-id></mixed-citation></ref><ref id="B42"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Markle</surname><given-names>J. G. M.</given-names></name><name><surname>Frank</surname><given-names>D. N.</given-names></name><name><surname>Mortin-Toth</surname><given-names>S.</given-names></name><name><surname>Robertson</surname><given-names>C. E.</given-names></name><name><surname>Feazel</surname><given-names>L. M.</given-names></name><name><surname>Rolle-Kampczyk</surname><given-names>U.</given-names></name><etal/></person-group> (<year>2013</year>). <article-title>Sex differences in the gut microbiome drive hormone-dependent regulation of autoimmunity.</article-title>
<source><italic>Science</italic></source>
<volume>339</volume>
<fpage>1084</fpage>&#x02013;<lpage>1088</lpage>. <pub-id pub-id-type="doi">10.1126/science.1233521</pub-id>
<?supplied-pmid 23328391?><pub-id pub-id-type="pmid">23328391</pub-id></mixed-citation></ref><ref id="B43"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maurice</surname><given-names>C. F.</given-names></name><name><surname>Haiser</surname><given-names>H. J.</given-names></name><name><surname>Turnbaugh</surname><given-names>P. J.</given-names></name></person-group> (<year>2013</year>). <article-title>Xenobiotics shape the physiology and gene expression of the active human gut microbiome.</article-title>
<source><italic>Cell</italic></source>
<volume>152</volume>
<fpage>39</fpage>&#x02013;<lpage>50</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2012.10.052</pub-id>
<?supplied-pmid 23332745?><pub-id pub-id-type="pmid">23332745</pub-id></mixed-citation></ref><ref id="B44"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McBain</surname><given-names>A. J.</given-names></name><name><surname>O&#x02019;Neill</surname><given-names>C. A.</given-names></name><name><surname>Amezquita</surname><given-names>A.</given-names></name><name><surname>Price</surname><given-names>L. J.</given-names></name><name><surname>Faust</surname><given-names>K.</given-names></name><name><surname>Tett</surname><given-names>A.</given-names></name><etal/></person-group> (<year>2019</year>). <article-title>Consumer safety considerations of skin and oral microbiome perturbation.</article-title>
<source><italic>Clin. Microbiol. Rev.</italic></source>
<volume>32</volume>
<fpage>e51</fpage>&#x02013;<lpage>e19</lpage>. <pub-id pub-id-type="doi">10.1128/CMR.00051-19</pub-id>
<?supplied-pmid 31366612?><pub-id pub-id-type="pmid">31366612</pub-id></mixed-citation></ref><ref id="B45"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Merten</surname><given-names>C.</given-names></name><name><surname>Schoonjans</surname><given-names>R.</given-names></name><name><surname>Di Gioia</surname><given-names>D.</given-names></name><name><surname>Pel&#x000e1;ez</surname><given-names>C.</given-names></name><name><surname>Sanz</surname><given-names>Y.</given-names></name><name><surname>Maurici</surname><given-names>D.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>Editorial: exploring the need to include microbiomes into EFSA&#x02019;s scientific assessments</article-title>. <source><italic>EFSA J.</italic></source>
<volume>18</volume>:<issue>e18061</issue>. <pub-id pub-id-type="doi">10.2903/j.efsa.2020.e18061</pub-id>
<?supplied-pmid 32874347?><pub-id pub-id-type="pmid">32874347</pub-id></mixed-citation></ref><ref id="B46"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>M&#x000e9;tris</surname><given-names>A.</given-names></name><name><surname>Barrett</surname><given-names>P.</given-names></name><name><surname>Price</surname><given-names>L.</given-names></name><name><surname>Klamert</surname><given-names>S.</given-names></name><name><surname>Fernandez-Piquer</surname><given-names>J.</given-names></name></person-group> (<year>2021</year>). <article-title>A tiered approach to risk assess microbiome perturbations induced by application of beauty and personal care products.</article-title>
<source><italic>Microb. Risk Anal.</italic></source>
<volume>20</volume>:<issue>100188</issue>. <pub-id pub-id-type="doi">10.1016/j.mran.2021.100188</pub-id></mixed-citation></ref><ref id="B47"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Monteagudo</surname><given-names>C.</given-names></name><name><surname>Robles-Aguilera</surname><given-names>V.</given-names></name><name><surname>Salcedo-Bellido</surname><given-names>I.</given-names></name><name><surname>G&#x000e1;lvez-Ontiveros</surname><given-names>Y.</given-names></name><name><surname>Samaniego-S&#x000e1;nchez</surname><given-names>C.</given-names></name><name><surname>Aguilera</surname><given-names>M.</given-names></name><etal/></person-group> (<year>2021</year>). <article-title>Dietary exposure to parabens and body mass index in an adolescent Spanish population.</article-title>
<source><italic>Environ. Res.</italic></source>
<volume>201</volume>:<issue>111548</issue>. <pub-id pub-id-type="doi">10.1016/j.envres.2021.111548</pub-id>
<?supplied-pmid 34166657?><pub-id pub-id-type="pmid">34166657</pub-id></mixed-citation></ref><ref id="B48"><mixed-citation publication-type="book"><collab>National Academies of Sciences, Engineering, and Medicine [NASEM]</collab> (<year>2018</year>). <source><italic>Environmental Chemicals, the Human Microbiome, and Health Risk: A Research Strategy.</italic></source>
<publisher-loc>Washington, D.C</publisher-loc>: <publisher-name>The National Academies Press</publisher-name>. <pub-id pub-id-type="doi">10.17226/24960</pub-id>
<?supplied-pmid 29431953?></mixed-citation></ref><ref id="B49"><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>O&#x02019;Neill</surname><given-names>J.</given-names></name></person-group> (<year>2016</year>). <source><italic>Tackling Drug-Resistant Infections Globally: Final Report and Recommendations (Report).</italic></source>
<publisher-loc>London</publisher-loc>: <publisher-name>Government of the United Kingdom</publisher-name>.</mixed-citation></ref><ref id="B50"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ortiz</surname><given-names>P.</given-names></name><name><surname>Torres-S&#x000e1;nchez</surname><given-names>A.</given-names></name><name><surname>L&#x000f3;pez-Moreno</surname><given-names>A.</given-names></name><name><surname>Cerk</surname><given-names>K.</given-names></name><name><surname>Ruiz-Moreno</surname><given-names>&#x000c1;</given-names></name><name><surname>Monteoliva-S&#x000e1;nchez</surname><given-names>M.</given-names></name><etal/></person-group> (<year>2022</year>). <article-title>Impact of cumulative environmental and dietary xenobiotics on human microbiota: risk assessment for one health.</article-title>
<source><italic>J. Xenobiotics</italic></source>
<volume>12</volume>
<fpage>56</fpage>&#x02013;<lpage>63</lpage>. <pub-id pub-id-type="doi">10.3390/jox12010006</pub-id>
<?supplied-pmid 35323221?><pub-id pub-id-type="pmid">35323221</pub-id></mixed-citation></ref><ref id="B51"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O&#x02019;Sullivan</surname><given-names>O.</given-names></name><name><surname>Cronin</surname><given-names>O.</given-names></name><name><surname>Clarke</surname><given-names>S. F.</given-names></name><name><surname>Murphy</surname><given-names>E. F.</given-names></name><name><surname>Molloy</surname><given-names>M. G.</given-names></name><name><surname>Shanahan</surname><given-names>F.</given-names></name><etal/></person-group> (<year>2015</year>). <article-title>Exercise and the microbiota.</article-title>
<source><italic>Gut Microbes</italic></source>
<volume>6</volume>
<fpage>131</fpage>&#x02013;<lpage>136</lpage>. <pub-id pub-id-type="doi">10.1080/19490976.2015.1011875</pub-id>
<?supplied-pmid 25800089?><pub-id pub-id-type="pmid">25800089</pub-id></mixed-citation></ref><ref id="B52"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O&#x02019;Toole</surname><given-names>P. W.</given-names></name><name><surname>Marchesi</surname><given-names>J. R.</given-names></name><name><surname>Hill</surname><given-names>C.</given-names></name></person-group> (<year>2017</year>). <article-title>Next-generation probiotics: the spectrum from probiotics to live biotherapeutics.</article-title>
<source><italic>Nat. Microbiol.</italic></source>
<volume>2</volume>
<fpage>1</fpage>&#x02013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1038/nmicrobiol.2017.57</pub-id>
<?supplied-pmid 28440276?><pub-id pub-id-type="pmid">28440276</pub-id></mixed-citation></ref><ref id="B53"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pan</surname><given-names>H.</given-names></name><name><surname>Feng</surname><given-names>J.</given-names></name><name><surname>He</surname><given-names>G.-X.</given-names></name><name><surname>Cerniglia</surname><given-names>C. E.</given-names></name><name><surname>Chen</surname><given-names>H.</given-names></name></person-group> (<year>2012</year>). <article-title>Evaluation of impact of exposure of Sudan azo dyes and their metabolites on human intestinal bacteria.</article-title>
<source><italic>Anaerobe</italic></source>
<volume>18</volume>
<fpage>445</fpage>&#x02013;<lpage>453</lpage>. <pub-id pub-id-type="doi">10.1016/j.anaerobe.2012.05.002</pub-id>
<?supplied-pmid 22634331?><pub-id pub-id-type="pmid">22634331</pub-id></mixed-citation></ref><ref id="B54"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patterson</surname><given-names>A. D.</given-names></name><name><surname>Turnbaugh</surname><given-names>P. J.</given-names></name></person-group> (<year>2014</year>). <article-title>Microbial determinants of biochemical individuality and their impact on toxicology and pharmacology.</article-title>
<source><italic>Cell Metab.</italic></source>
<volume>20</volume>
<fpage>761</fpage>&#x02013;<lpage>768</lpage>. <pub-id pub-id-type="doi">10.1016/j.cmet.2014.07.002</pub-id>
<?supplied-pmid 25156450?><pub-id pub-id-type="pmid">25156450</pub-id></mixed-citation></ref><ref id="B55"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peris-Bondia</surname><given-names>F.</given-names></name><name><surname>Latorre</surname><given-names>A.</given-names></name><name><surname>Artacho</surname><given-names>A.</given-names></name><name><surname>Moya</surname><given-names>A.</given-names></name><name><surname>D&#x02019;Auria</surname><given-names>G.</given-names></name></person-group> (<year>2011</year>). <article-title>The active human gut microbiota differs from the total microbiota.</article-title>
<source><italic>PLoS One</italic></source>
<volume>6</volume>:<issue>e22448</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0022448</pub-id>
<?supplied-pmid 21829462?><pub-id pub-id-type="pmid">21829462</pub-id></mixed-citation></ref><ref id="B56"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peterson</surname><given-names>L. W.</given-names></name><name><surname>Artis</surname><given-names>D.</given-names></name></person-group> (<year>2014</year>). <article-title>Intestinal epithelial cells: regulators of barrier function and immune homeostasis.</article-title>
<source><italic>Nat. Rev. Immunol.</italic></source>
<volume>14</volume>
<fpage>141</fpage>&#x02013;<lpage>153</lpage>. <pub-id pub-id-type="doi">10.1038/nri3608</pub-id>
<?supplied-pmid 24566914?><pub-id pub-id-type="pmid">24566914</pub-id></mixed-citation></ref><ref id="B57"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rafii</surname><given-names>F.</given-names></name><name><surname>Franklin</surname><given-names>W.</given-names></name><name><surname>Cerniglia</surname><given-names>C. E.</given-names></name></person-group> (<year>1990</year>). <article-title>Azoreductase activity of anaerobic bacteria isolated from human intestinal microflora.</article-title>
<source><italic>Appl. Environ. Microbiol.</italic></source>
<volume>56</volume>
<fpage>2146</fpage>&#x02013;<lpage>2151</lpage>. <pub-id pub-id-type="doi">10.1128/aem.56.7.2146-2151.1990</pub-id>
<?supplied-pmid 2202258?><pub-id pub-id-type="pmid">2202258</pub-id></mixed-citation></ref><ref id="B58"><mixed-citation publication-type="journal"><collab>Regulation (EC) No 178/2002</collab> (<year>2002</year>). <source><italic>Regulation (EC) No 178/2002 of the European Parliament and of the Council of 28 January 2002 Laying Down the General Principles and Requirements of Food Law, Establishing the European Food Safety Authority and Laying Down Procedures in Matters of Food Safety. Official Journal of the European Communities&#x02013;Legislation Series.</italic></source> Available online at: <ext-link xlink:href="http://data.europa.eu/eli/reg/2002/178/oj/eng" ext-link-type="uri">http://data.europa.eu/eli/reg/2002/178/oj/eng</ext-link>
<comment>(accessed February 03, 2022)</comment>.</mixed-citation></ref><ref id="B59"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ribado</surname><given-names>J. V.</given-names></name><name><surname>Ley</surname><given-names>C.</given-names></name><name><surname>Haggerty</surname><given-names>T. D.</given-names></name><name><surname>Tkachenko</surname><given-names>E.</given-names></name><name><surname>Bhatt</surname><given-names>A. S.</given-names></name><name><surname>Parsonnet</surname><given-names>J.</given-names></name></person-group> (<year>2017</year>). <article-title>Household triclosan and triclocarban effects on the infant and maternal microbiome.</article-title>
<source><italic>EMBO Mol. Med.</italic></source>
<volume>9</volume>
<fpage>1732</fpage>&#x02013;<lpage>1741</lpage>. <pub-id pub-id-type="doi">10.15252/emmm.201707882</pub-id>
<?supplied-pmid 29030459?><pub-id pub-id-type="pmid">29030459</pub-id></mixed-citation></ref><ref id="B60"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robles-Aguilera</surname><given-names>V.</given-names></name><name><surname>G&#x000e1;lvez-Ontiveros</surname><given-names>Y.</given-names></name><name><surname>Rodrigo</surname><given-names>L.</given-names></name><name><surname>Salcedo-Bellido</surname><given-names>I.</given-names></name><name><surname>Aguilera</surname><given-names>M.</given-names></name><name><surname>Zafra-G&#x000f3;mez</surname><given-names>A.</given-names></name><etal/></person-group> (<year>2021</year>). <article-title>Factors associated with exposure to dietary bisphenols in adolescents.</article-title>
<source><italic>Nutrients</italic></source>
<volume>13</volume>:<issue>1553</issue>. <pub-id pub-id-type="doi">10.3390/nu13051553</pub-id>
<?supplied-pmid 34062990?><pub-id pub-id-type="pmid">34062990</pub-id></mixed-citation></ref><ref id="B61"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rodricks</surname><given-names>J.</given-names></name><name><surname>Huang</surname><given-names>Y.</given-names></name><name><surname>Mantus</surname><given-names>E.</given-names></name><name><surname>Shubat</surname><given-names>P.</given-names></name></person-group> (<year>2019</year>). <article-title>Do interactions between environmental chemicals and the human microbiome need to be considered in risk assessments?</article-title>
<source><italic>Risk Anal.</italic></source>
<volume>39</volume>
<fpage>2353</fpage>&#x02013;<lpage>2358</lpage>. <pub-id pub-id-type="doi">10.1111/risa.13316</pub-id>
<?supplied-pmid 31070803?><pub-id pub-id-type="pmid">31070803</pub-id></mixed-citation></ref><ref id="B62"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rozman</surname><given-names>U.</given-names></name><name><surname>Pu&#x00161;nik</surname><given-names>M.</given-names></name><name><surname>Kmetec</surname><given-names>S.</given-names></name><name><surname>Duh</surname><given-names>D.</given-names></name><name><surname>&#x00160;ostar Turk</surname><given-names>S.</given-names></name></person-group> (<year>2021</year>). <article-title>Reduced susceptibility and increased resistance of bacteria against disinfectants: a systematic review.</article-title>
<source><italic>Microorganisms</italic></source>
<volume>9</volume>:<issue>2550</issue>. <pub-id pub-id-type="doi">10.3390/microorganisms9122550</pub-id>
<?supplied-pmid 34946151?><pub-id pub-id-type="pmid">34946151</pub-id></mixed-citation></ref><ref id="B63"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ruiz-Ojeda</surname><given-names>F. J.</given-names></name><name><surname>Plaza-D&#x000ed;az</surname><given-names>J.</given-names></name><name><surname>S&#x000e1;ez-Lara</surname><given-names>M. J.</given-names></name><name><surname>Gil</surname><given-names>A.</given-names></name></person-group> (<year>2019</year>). <article-title>Effects of sweeteners on the gut microbiota: a review of experimental studies and clinical trials.</article-title>
<source><italic>Adv. Nutr.</italic></source>
<volume>10</volume>
<fpage>S31</fpage>&#x02013;<lpage>S48</lpage>. <pub-id pub-id-type="doi">10.1093/advances/nmy037</pub-id>
<?supplied-pmid 30721958?><pub-id pub-id-type="pmid">30721958</pub-id></mixed-citation></ref><ref id="B64"><mixed-citation publication-type="book"><collab>Scientific Committee on Consumer Safety [SCCS]</collab> (<year>2010</year>). <source><italic>Opinion on Triclosan (Antimicrobial Resistance) (No. SCCP/1251/09). European Commission. Directorate-General for Health and Consumers.</italic></source>
<publisher-loc>Brussels</publisher-loc>: <publisher-name>SCCS</publisher-name>.</mixed-citation></ref><ref id="B65"><mixed-citation publication-type="book"><collab>Scientific Committee on Emerging and Newly Identified Health Risks</collab> (<year>2009</year>). <source><italic>Assessment of the Antibiotic Resistance Effects of Biocides. European Commission. Directorate-General for Health and Consumers.</italic></source>
<publisher-loc>Brussels</publisher-loc>: <publisher-name>Scientific Committee on Emerging and Newly Identified Health Risks</publisher-name>.</mixed-citation></ref><ref id="B66"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Selwyn</surname><given-names>F. P.</given-names></name><name><surname>Cheng</surname><given-names>S. L.</given-names></name><name><surname>Bammler</surname><given-names>T. K.</given-names></name><name><surname>Prasad</surname><given-names>B.</given-names></name><name><surname>Vrana</surname><given-names>M.</given-names></name><name><surname>Klaassen</surname><given-names>C.</given-names></name><etal/></person-group> (<year>2015</year>). <article-title>Developmental regulation of drug-processing genes in livers of germ-free mice.</article-title>
<source><italic>Toxicol. Sci.</italic></source>
<volume>147</volume>
<fpage>84</fpage>&#x02013;<lpage>103</lpage>. <pub-id pub-id-type="doi">10.1093/toxsci/kfv110</pub-id>
<?supplied-pmid 26032512?><pub-id pub-id-type="pmid">26032512</pub-id></mixed-citation></ref><ref id="B67"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Selwyn</surname><given-names>F. P.</given-names></name><name><surname>Cheng</surname><given-names>S. L.</given-names></name><name><surname>Klaassen</surname><given-names>C. D.</given-names></name><name><surname>Cui</surname><given-names>J. Y.</given-names></name></person-group> (<year>2016</year>). <article-title>Regulation of hepatic drug-metabolizing enzymes in germ-free mice by conventionalization and probiotics.</article-title>
<source><italic>Drug Metab. Dispos.</italic></source>
<volume>44</volume>
<fpage>262</fpage>&#x02013;<lpage>274</lpage>. <pub-id pub-id-type="doi">10.1124/dmd.115.067504</pub-id>
<?supplied-pmid 26586378?><pub-id pub-id-type="pmid">26586378</pub-id></mixed-citation></ref><ref id="B68"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Signore</surname><given-names>M. A.</given-names></name><name><surname>De Pascali</surname><given-names>C.</given-names></name><name><surname>Giampetruzzi</surname><given-names>L.</given-names></name><name><surname>Siciliano</surname><given-names>P. A.</given-names></name><name><surname>Francioso</surname><given-names>L.</given-names></name></person-group> (<year>2021</year>). <article-title>Gut-on-Chip microphysiological systems: Latest advances in the integration of sensing strategies and adoption of mature detection mechanisms.</article-title>
<source><italic>Sens. Bio-Sens. Res.</italic></source>
<volume>33</volume>:<issue>100443</issue>. <pub-id pub-id-type="doi">10.1016/j.sbsr.2021.100443</pub-id></mixed-citation></ref><ref id="B69"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soni</surname><given-names>M. G.</given-names></name><name><surname>Burdock</surname><given-names>G. A.</given-names></name><name><surname>Taylor</surname><given-names>S. L.</given-names></name><name><surname>Greenberg</surname><given-names>N. A.</given-names></name></person-group> (<year>2001</year>). <article-title>Safety assessment of propyl paraben: a review of the published literature.</article-title>
<source><italic>Food Chem. Toxicol. Int. J. Publ. Br. Ind. Biol. Res. Assoc.</italic></source>
<volume>39</volume>
<fpage>513</fpage>&#x02013;<lpage>532</lpage>. <pub-id pub-id-type="doi">10.1016/s0278-6915(00)00162-9</pub-id></mixed-citation></ref><ref id="B70"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soni</surname><given-names>M. G.</given-names></name><name><surname>Carabin</surname><given-names>I. G.</given-names></name><name><surname>Burdock</surname><given-names>G. A.</given-names></name></person-group> (<year>2005</year>). <article-title>Safety assessment of esters of p-hydroxybenzoic acid (parabens).</article-title>
<source><italic>Food Chem. Toxicol. Int. J. Publ. Br. Ind. Biol. Res. Assoc.</italic></source>
<volume>43</volume>
<fpage>985</fpage>&#x02013;<lpage>1015</lpage>. <pub-id pub-id-type="doi">10.1016/j.fct.2005.01.020</pub-id>
<?supplied-pmid 15833376?><pub-id pub-id-type="pmid">15833376</pub-id></mixed-citation></ref><ref id="B71"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soni</surname><given-names>M. G.</given-names></name><name><surname>Taylor</surname><given-names>S. L.</given-names></name><name><surname>Greenberg</surname><given-names>N. A.</given-names></name><name><surname>Burdock</surname><given-names>G. A.</given-names></name></person-group> (<year>2002</year>). <article-title>Evaluation of the health aspects of methyl paraben: a review of the published literature.</article-title>
<source><italic>Food Chem. Toxicol. Int. J. Publ. Br. Ind. Biol. Res. Assoc.</italic></source>
<volume>40</volume>
<fpage>1335</fpage>&#x02013;<lpage>1373</lpage>. <pub-id pub-id-type="doi">10.1016/s0278-6915(02)00107-2</pub-id></mixed-citation></ref><ref id="B72"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sonnenburg</surname><given-names>J. L.</given-names></name><name><surname>B&#x000e4;ckhed</surname><given-names>F.</given-names></name></person-group> (<year>2016</year>). <article-title>Diet&#x02013;microbiota interactions as moderators of human metabolism.</article-title>
<source><italic>Nature</italic></source>
<volume>535</volume>
<fpage>56</fpage>&#x02013;<lpage>64</lpage>. <pub-id pub-id-type="doi">10.1038/nature18846</pub-id>
<?supplied-pmid 27383980?><pub-id pub-id-type="pmid">27383980</pub-id></mixed-citation></ref><ref id="B73"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spanogiannopoulos</surname><given-names>P.</given-names></name><name><surname>Bess</surname><given-names>E. N.</given-names></name><name><surname>Carmody</surname><given-names>R. N.</given-names></name><name><surname>Turnbaugh</surname><given-names>P. J.</given-names></name></person-group> (<year>2016</year>). <article-title>The microbial pharmacists within us: a metagenomic view of xenobiotic metabolism.</article-title>
<source><italic>Nat. Rev. Microbiol.</italic></source>
<volume>14</volume>
<fpage>273</fpage>&#x02013;<lpage>287</lpage>. <pub-id pub-id-type="doi">10.1038/nrmicro.2016.17</pub-id>
<?supplied-pmid 26972811?><pub-id pub-id-type="pmid">26972811</pub-id></mixed-citation></ref><ref id="B74"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tian</surname><given-names>L.</given-names></name><name><surname>Wang</surname><given-names>X.-W.</given-names></name><name><surname>Wu</surname><given-names>A.-K.</given-names></name><name><surname>Fan</surname><given-names>Y.</given-names></name><name><surname>Friedman</surname><given-names>J.</given-names></name><name><surname>Dahlin</surname><given-names>A.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>Deciphering functional redundancy in the human microbiome.</article-title>
<source><italic>Nat. Commun.</italic></source>
<volume>11</volume>:<issue>6217</issue>. <pub-id pub-id-type="doi">10.1038/s41467-020-19940-1</pub-id>
<?supplied-pmid 33277504?><pub-id pub-id-type="pmid">33277504</pub-id></mixed-citation></ref><ref id="B75"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Torres-S&#x000e1;nchez</surname><given-names>A.</given-names></name><name><surname>Pardo-Cacho</surname><given-names>J.</given-names></name><name><surname>L&#x000f3;pez-Moreno</surname><given-names>A.</given-names></name><name><surname>Ruiz-Moreno</surname><given-names>&#x000c1;</given-names></name><name><surname>Cerk</surname><given-names>K.</given-names></name><name><surname>Aguilera</surname><given-names>M.</given-names></name></person-group> (<year>2021</year>). <article-title>Antimicrobial effects of potential probiotics of <italic>Bacillus</italic> spp. isolated from human microbiota: in vitro and in silico methods.</article-title>
<source><italic>Microorganisms</italic></source>
<volume>9</volume>:<issue>1615</issue>. <pub-id pub-id-type="doi">10.3390/microorganisms9081615</pub-id>
<?supplied-pmid 34442694?><pub-id pub-id-type="pmid">34442694</pub-id></mixed-citation></ref><ref id="B76"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tremaroli</surname><given-names>V.</given-names></name><name><surname>Karlsson</surname><given-names>F.</given-names></name><name><surname>Werling</surname><given-names>M.</given-names></name><name><surname>St&#x000e5;hlman</surname><given-names>M.</given-names></name><name><surname>Kovatcheva-Datchary</surname><given-names>P.</given-names></name><name><surname>Olbers</surname><given-names>T.</given-names></name><etal/></person-group> (<year>2015</year>). <article-title>Roux-en-Y gastric bypass and vertical banded gastroplasty induce long-term changes on the human gut microbiome contributing to fat mass regulation.</article-title>
<source><italic>Cell Metab.</italic></source>
<volume>22</volume>
<fpage>228</fpage>&#x02013;<lpage>238</lpage>. <pub-id pub-id-type="doi">10.1016/j.cmet.2015.07.009</pub-id>
<?supplied-pmid 26244932?><pub-id pub-id-type="pmid">26244932</pub-id></mixed-citation></ref><ref id="B77"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trinh</surname><given-names>P.</given-names></name><name><surname>Zaneveld</surname><given-names>J. R.</given-names></name><name><surname>Safranek</surname><given-names>S.</given-names></name><name><surname>Rabinowitz</surname><given-names>P. M.</given-names></name></person-group> (<year>2018</year>). <article-title>One health relationships between human, animal, and environmental microbiomes: a mini-review.</article-title>
<source><italic>Front. Public Health.</italic></source>
<volume>6</volume>:<issue>235</issue>. <pub-id pub-id-type="doi">10.3389/fpubh.2018.00235</pub-id>
<?supplied-pmid 30214898?><pub-id pub-id-type="pmid">30214898</pub-id></mixed-citation></ref><ref id="B78"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ulluwishewa</surname><given-names>D.</given-names></name><name><surname>Anderson</surname><given-names>R. C.</given-names></name><name><surname>McNabb</surname><given-names>W. C.</given-names></name><name><surname>Moughan</surname><given-names>P. J.</given-names></name><name><surname>Wells</surname><given-names>J. M.</given-names></name><name><surname>Roy</surname><given-names>N. C.</given-names></name></person-group> (<year>2011</year>). <article-title>Regulation of tight junction permeability by intestinal bacteria and dietary components.</article-title>
<source><italic>J. Nutr.</italic></source>
<volume>141</volume>
<fpage>769</fpage>&#x02013;<lpage>776</lpage>. <pub-id pub-id-type="doi">10.3945/jn.110.135657</pub-id>
<?supplied-pmid 21430248?><pub-id pub-id-type="pmid">21430248</pub-id></mixed-citation></ref><ref id="B79"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Valkova</surname><given-names>N.</given-names></name><name><surname>L&#x000e9;pine</surname><given-names>F.</given-names></name><name><surname>Bollet</surname><given-names>C.</given-names></name><name><surname>Dupont</surname><given-names>M.</given-names></name><name><surname>Villemur</surname><given-names>R.</given-names></name></person-group> (<year>2002</year>). <article-title>prbA, a gene coding for an esterase hydrolyzing parabens in <italic>Enterobacter cloacae</italic> and <italic>Enterobacter</italic> gergoviae strains.</article-title>
<source><italic>J. Bacteriol.</italic></source>
<volume>184</volume>
<fpage>5011</fpage>&#x02013;<lpage>5017</lpage>. <pub-id pub-id-type="doi">10.1128/JB.184.18.5011-5017.2002</pub-id>
<?supplied-pmid 12193616?><pub-id pub-id-type="pmid">12193616</pub-id></mixed-citation></ref><ref id="B80"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van den Abbeele</surname><given-names>P.</given-names></name><name><surname>Roos</surname><given-names>S.</given-names></name><name><surname>Eeckhaut</surname><given-names>V.</given-names></name><name><surname>MacKenzie</surname><given-names>D. A.</given-names></name><name><surname>Derde</surname><given-names>M.</given-names></name><name><surname>Verstraete</surname><given-names>W.</given-names></name><etal/></person-group> (<year>2012</year>). <article-title>Incorporating a mucosal environment in a dynamic gut model results in a more representative colonization by <italic>lactobacilli</italic>.</article-title>
<source><italic>Microb. Biotechnol.</italic></source>
<volume>5</volume>
<fpage>106</fpage>&#x02013;<lpage>115</lpage>. <pub-id pub-id-type="doi">10.1111/j.1751-7915.2011.00308.x</pub-id>
<?supplied-pmid 21989255?><pub-id pub-id-type="pmid">21989255</pub-id></mixed-citation></ref><ref id="B81"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Q.-P.</given-names></name><name><surname>Browman</surname><given-names>D.</given-names></name><name><surname>Herzog</surname><given-names>H.</given-names></name><name><surname>Neely</surname><given-names>G. G.</given-names></name></person-group> (<year>2018</year>). <article-title>Non-nutritive sweeteners possess a bacteriostatic effect and alter gut microbiota in mice.</article-title>
<source><italic>PLoS One</italic></source>
<volume>13</volume>:<issue>e0199080</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0199080</pub-id>
<?supplied-pmid 29975731?><pub-id pub-id-type="pmid">29975731</pub-id></mixed-citation></ref><ref id="B82"><mixed-citation publication-type="journal"><collab>World Health Organization</collab> (<year>2021</year>). <source><italic>Antimicrobial Resistance. Antimicrob. Resist.</italic></source> Available Online at URL <ext-link xlink:href="https://www.who.int/news-room/fact-sheets/detail/antimicrobial-resistance" ext-link-type="uri">https://www.who.int/news-room/fact-sheets/detail/antimicrobial-resistance</ext-link>
<comment>(accessed Janauary.20.22)</comment></mixed-citation></ref><ref id="B83"><mixed-citation publication-type="book"><collab>World Health Organization</collab> (<year>2015</year>). <source><italic>Global Action Plan on Antimicrobial Resistance.</italic></source>
<publisher-loc>Geneva</publisher-loc>: <publisher-name>World Health Organization</publisher-name>.</mixed-citation></ref><ref id="B84"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>H.</given-names></name><name><surname>Heinze</surname><given-names>T. M.</given-names></name><name><surname>Chen</surname><given-names>S.</given-names></name><name><surname>Cerniglia</surname><given-names>C. E.</given-names></name><name><surname>Chen</surname><given-names>H.</given-names></name></person-group> (<year>2007</year>). <article-title>Anaerobic metabolism of 1-Amino-2-naphthol-based azo dyes (Sudan Dyes) by human intestinal microflora.</article-title>
<source><italic>Appl. Environ. Microbiol.</italic></source>
<volume>73</volume>
<fpage>7759</fpage>&#x02013;<lpage>7762</lpage>. <pub-id pub-id-type="doi">10.1128/AEM.01410-07</pub-id>
<?supplied-pmid 17933925?><pub-id pub-id-type="pmid">17933925</pub-id></mixed-citation></ref><ref id="B85"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yatsunenko</surname><given-names>T.</given-names></name><name><surname>Rey</surname><given-names>F. E.</given-names></name><name><surname>Manary</surname><given-names>M. J.</given-names></name><name><surname>Trehan</surname><given-names>I.</given-names></name><name><surname>Dominguez-Bello</surname><given-names>M. G.</given-names></name><name><surname>Contreras</surname><given-names>M.</given-names></name><etal/></person-group> (<year>2012</year>). <article-title>Human gut microbiome viewed across age and geography.</article-title>
<source><italic>Nature</italic></source>
<volume>486</volume>
<fpage>222</fpage>&#x02013;<lpage>227</lpage>. <pub-id pub-id-type="doi">10.1038/nature11053</pub-id>
<?supplied-pmid 22699611?><pub-id pub-id-type="pmid">22699611</pub-id></mixed-citation></ref></ref-list></back></article>